| CD1a | +++ |
| CD1c | + |
| CD4 | ++ |
| CD5 | − |
| CD7 | +/− |
| CD8 | − |
| CD11b | ++ |
| CD11c | ++ |
| CD13 | +++ |
| CD14 | +/− |
| CD33 | ++ |
| CD40 | ++ |
| CD44 | ++ |
| CD45RA | + |
| CD45RO | ++ |
| CD54 | +++ |
| CD80 | + |
| CD83 | ++ |
| CD86 | + |
| CD116 (GM-CSFR) | + |
| CD123 (IL-3Rα) | +/− |
| HLA-DR | +++ |
| CD1a | +++ |
| CD1c | + |
| CD4 | ++ |
| CD5 | − |
| CD7 | +/− |
| CD8 | − |
| CD11b | ++ |
| CD11c | ++ |
| CD13 | +++ |
| CD14 | +/− |
| CD33 | ++ |
| CD40 | ++ |
| CD44 | ++ |
| CD45RA | + |
| CD45RO | ++ |
| CD54 | +++ |
| CD80 | + |
| CD83 | ++ |
| CD86 | + |
| CD116 (GM-CSFR) | + |
| CD123 (IL-3Rα) | +/− |
| HLA-DR | +++ |
Flow cytometry analyses were performed by day 10 on in vitro–derived dendritic cells generated from CD34hiCD33lo human thymic progenitors in multicytokine-supported cultures.
GM-CSFR indicates granulocyte macrophage–colony-stimulating factor receptor; IL-3Rα, interleukin 3 receptor alpha.